Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.
about
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family FlaviviridaeScavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityInitiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type IPotential cellular receptors involved in hepatitis C virus entry into cellsImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus ProductionCharacterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptorHuman serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionCharacterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein.Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapyConservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell AttachmentPersistent and transient replication of full-length hepatitis C virus genomes in cell cultureCharacterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing ParticlesAssociation between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density GradientsRole of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes.Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter VirusesDifferential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus ParticlesHepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissectionCharacterization of the genome and structural proteins of hepatitis C virus resolved from infected human liverFormation of native hepatitis C virus glycoprotein complexes.Studying Hepatitis C Virus: Making the Best of a Bad VirusHepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage dropletsPreferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteinsExpression of hepatitis C virus proteins in epithelial intestinal cells in vivoHuman Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell CultureSerum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 DependentTear fluid of hepatitis C virus carriers could be infectiousEfficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like ParticlesBinding of liver derived, low density hepatitis C virus to human hepatoma cellsApolipoprotein C1 Association with Hepatitis C VirusCharacterization of hepatitis C RNA-containing particles from human liver by density and sizeIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesSecretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive LipoproteinsMutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus InfectivityTargeting host factors: A novel rationale for the management of hepatitis C virusA hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humansTransactivating effect of hepatitis C virus core protein: a suppression subtractive hybridization study.The missing pieces of the HCV entry puzzle.Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA.
P2860
Q24609524-E6C35318-F542-405E-B67A-82A8A7AB2BA5Q24672232-06DE6106-5A38-4985-A331-E0B03FE2A781Q24676039-75004A86-6DC0-43C7-A221-49735F85CDE5Q24795289-8ABFD9E5-D7FC-4982-82FC-D89158E78459Q26864485-651EEF41-42A6-428E-A732-F33F3044785CQ27314827-948DCA12-6113-4036-BEC4-5A23EBAF5A5AQ27469307-A7654033-B2A7-46FF-8AA0-DBA9189F0C1DQ27469507-A46EF73A-4172-48CF-A0BF-10F0BD5E3D54Q27469553-D69C462C-AD72-407D-9359-FF5BDEC14B94Q27469719-4A1F55F2-FCDD-49E7-8C36-67592402F960Q27469804-B3059963-1F69-44AF-9F6D-619E00557360Q27472869-A0A0B532-B04F-45E3-98B5-F33629C35E73Q27472884-CBE06233-6249-446E-ADFF-F16426010538Q27473044-08DB91A2-4CE0-46A4-AB9C-97F5627AED03Q27473066-D82E4F87-0039-4475-A6DF-FEB42D4EABCFQ27473226-8A702892-0160-47B5-9CE6-38907B83441FQ27477620-A04FE2AE-FE6E-48DF-82BE-D43CA3A060E4Q27478121-B57800F0-85F7-4F92-8F99-20936C59D506Q27478136-D7A82587-D636-4F20-9DB5-391A1D5FEA62Q27480776-9852AAB7-6B69-4A7D-9CB8-4D875767AD7DQ27481034-2735BDF7-FD98-4FC6-9E2E-566C047F7D36Q27481061-86C80361-D582-4D71-9C1C-1241AA74747CQ27481398-8E767EA8-06A0-45AF-889E-860538618591Q27482130-73F918C2-503C-4F25-BE95-A5A2228DBC07Q27485012-2347F998-3B52-4237-BA96-1AC66AC65277Q27485298-3B9B912A-088F-4B77-BBC6-B215F07B09F2Q27485658-AFD64B2A-4DDE-4AE9-9897-3A0AF7199501Q27486405-1E414DDB-7BAA-462B-803D-8AA7F2619012Q27486525-D6162C10-E230-4544-B1C7-A45B858E7890Q27486923-58FB7F52-8C22-4FAA-9ACA-20E35166C066Q27486986-9EB41224-BBFA-4335-B3A9-B8E42E8CCC76Q27487399-CE79F7DF-90D7-480C-80FA-933D58BA2D3FQ27487558-DA349BEE-F4EC-428F-967A-6F13C7473677Q27488430-C57BD3DD-DF99-409A-AD5F-0C87266F4A1EQ27488999-C0ACA42A-2CE6-4B0F-AEEE-159D3914D0D7Q28488268-C5C34C44-241C-47A6-947B-54B010977399Q31076773-A2D6B11B-3446-4BA2-B7DA-59C8271F7D50Q33360674-75709112-C1AC-45A2-B817-A8A86492958EQ33877342-CD2656AA-F218-426D-9C81-9236D0F22C31Q33959072-7430DEDE-CFDE-406E-B23B-80E485A88E64
P2860
Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Density heterogeneities of hep ...... oproteins and immunoglobulins.
@en
Density heterogeneities of hep ...... oproteins and immunoglobulins.
@nl
type
label
Density heterogeneities of hep ...... oproteins and immunoglobulins.
@en
Density heterogeneities of hep ...... oproteins and immunoglobulins.
@nl
prefLabel
Density heterogeneities of hep ...... oproteins and immunoglobulins.
@en
Density heterogeneities of hep ...... oproteins and immunoglobulins.
@nl
P2093
P356
P1476
Density heterogeneities of hep ...... oproteins and immunoglobulins.
@en
P2093
P2888
P304
P356
10.1007/BF00191948
P577
1993-12-01T00:00:00Z